Basics Immunovant, Inc. IPO Date: June 7, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.52B Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 2.78% Avg Daily Range (30 D): $0.37 | 2.21% Avg Daily Range (90 D): $0.41 | 2.68% Institutional Daily Volume Avg Daily Volume: .83M Avg Daily Volume (30 D): 1.03M Avg Daily Volume (90 D): 1.18M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 2,727 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $1.93M Avg Inst. Trade (90 D): $2.41M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.47M Avg Closing Trade (30 D): $2.35M Avg Closing Trade (90 D): $3.02M Avg Closing Volume: 153.93K     News Aug 11, 2025 @ 11:27 AM Immunovant Posts 34% R&D Jump in Q1 Source: Jesterai Sep 9, 2024 @ 6:08 PM IMVT Stock Up on Upbeat Data From Graves' Disease ... Source: Zacks, Benzinga Contributor Sep 9, 2024 @ 7:55 AM Immunovant Provides Update on Graves’ Disea... Source: N/A Jul 4, 2024 @ 8:01 PM Thyroid Eye Disease Market to Accelerate Substanti... Source: Delveinsight Jun 28, 2024 @ 3:30 PM Immunovant (IMVT) Down 1.6% Since Last Earnings Re... Source: Zacks Equity Research Financials   TTM Q4 2025 FY 2025 Basic EPS $-2.73 $-2.73 Diluted EPS $-2.73 $-2.73 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -413.84M $ $ -413.84M Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ 78.61M $ $ 78.61M PE Ratio